Companies whose shares are expected to trade actively in today’s session are J.C. Penney Company, Inc. (NYSE:JCP), A. Schulman Inc (NASDAQ:SHLM), Medley Capital Corp (NYSE:MCC), Starwood Property Trust, Inc. (NYSE:STWD), STAAR Surgical Company (NASDAQ:STAA) and 3SBio Inc. (ADR) (NSDAQ:SSRX).
J.C. Penney Company, Inc. (NYSE:JCP): The retailer has ousted chief executive officer Ron Johnson after his strategies failed to revive the company’s 1,100 stores. Hedge fund manager Bill Ackman hired Johnson to revamp the company. Johnson will be replaced by Myron Ullman, who ran the retailer until November 2011. Shares skidded 8.32 percent to $15.37 in the early session.
A. Schulman Inc (NASDAQ:SHLM): The company’s second quarter profits rose 30 percent due a tax benefit. The company said it will continue with its restructuring efforts in the weakening European market. A. Schulman is also consolidating its business in Brazil. The company issued downbeat guidance for the full year. Shares were down 5.9 percent to $28.
Medley Capital Corp (NYSE:MCC): The investment management company announced plans to offer 4 million shares. Medley will use the proceeds to repay a portion of its debts, finance new opportunities and for general corporate purposes. As of January 14, the company had 28.66 million outstanding shares. Shares slipped 2.92 percent to $14.64 in the early session.
Starwood Property Trust, Inc. (NYSE:STWD): The company will be offering 26.5 million shares. Starwood said it will use the proceeds to purchase commercial-mortgage loans, and a few other assets and investments. As of March 31, the real estate investment trust had about 135.7 million outstanding shares. Prices were down 2.91 percent to $27.40 in early market trading.
STAAR Surgical Company (NASDAQ:STAA): The company issued solid first quarter sales guidance that topped Wall Street’s estimates. Staar said sales of its Visian ICL lens were up 24 percent. Shares surged 21.78 percent to $6.71 in the early session.
3SBio Inc. (ADR) (NASDAQ:SSRX): Decade Sunshine Ltd has offered to take the Chinese biotech company private, but OrbiMed Advisors LLC opposed the offer. OrbiMed is the largest shareholder of 3SBio with 19 percent stake. American shares of the company went up 2.30 percent to $15.60 in the early session.